alpha-amanitin has been researched along with Peritoneal Carcinomatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, F; Ikeda, M; Ishida, K; Ito, C; Ito, K; Iwaya, T; Katagiri, H; Kume, K; Miura, S; Nishizuka, SS; Ohmori, Y; Sato, KA | 1 |
1 other study(ies) available for alpha-amanitin and Peritoneal Carcinomatosis
Article | Year |
---|---|
α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15.
Topics: Alpha-Amanitin; Animals; Cell Line, Tumor; Cisplatin; Down-Regulation; Drug Resistance; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; HT29 Cells; Humans; MCF-7 Cells; Mice; Peritoneal Neoplasms; Proteomics; Secondary Prevention; TATA-Binding Protein Associated Factors; Transcription, Genetic; Xenograft Model Antitumor Assays | 2016 |